Application of anticoagulants after transjugular intrahepatic portosystemic shunt
10.3969/j.issn.1001-5256.2018.10.040
- VernacularTitle:抗凝药物在经颈静脉肝内门体分流术后的应用
- Author:
Mingyuan JIANG
1
;
Hua HUANG
;
Mingliang LU
Author Information
1. Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming 650101 China
- Publication Type:Research Article
- Keywords:
portasystemic shunt, transjugular intrahepatic;
venous thrombosis;
anticoagulants;
review
- From:
Journal of Clinical Hepatology
2018;34(10):2241-2244
- CountryChina
- Language:Chinese
-
Abstract:
Transjugular intrahepatic portosystemic shunt (TIPS), after nearly 30 years of continuous exploration and development, has been widely used in the treatment of complications of portal hypertension. TIPS has significant advantages in acute esophagogastric variceal bleeding, prevention of rebleeding, refractory peritoneal effusion, and Budd-Chiari syndrome; however, if postoperative anticoagulant measures are inappropriate, it can cause several complications, such as stent dysfunction and acute thrombosis, and lead to the recurrence of the symptoms of portal hypertension before TIPS, which greatly affects middle- and long-term clinical outcomes and survival rate. Maintenance of stent patency is the key to good postoperative treatment outcome, and therefore, anticoagulants play an important role in the prevention and treatment of post-TIPS thrombosis. At present, no consensus has been reached on post-TIPS anticoagulant therapy in China and foreign countries. This article reviews the research advances in the application of anticoagulants after TIPS.
